WebApr 1, 2024 · – Ironwood capitalizing on GI leadership and expertise in an effort to bring innovative therapies to patients – – Strategy centered on accelerating LINZESS ® (linaclotide) growth and advancing late-stage programs IW-3718 and MD-7246 – – Business poised to drive revenue growth and begin generating profits – Ironwood … WebDennis A. Ausiello, M.D.Marsha H. FanucciMargaret A. Hamburg, M.D.David E.I. Pyott, ChairAmy W. Schulman. Recommends to the Board the persons to be nominated for election as directors at any meeting of stockholders; develop and recommend to the Board a set of corporate governance principles applicable to the Company; and oversee the …
Cyclerion Therapeutics Enters into Exclusive Negotiation Period …
WebFeb 26, 2024 · Peter Hecht, Ironwood’s current chief executive officer (CEO) and expected CEO of Cyclerion following the planned spin-off, stated, “We are grateful for the strong support from the outstanding and experienced group of investors who are participating in … WebMar 16, 2024 · SAIC’s board of directors will also welcome new board fellow, Mike McGrew, executive vice president, chief communications and corporate social responsibility and diversity officer for ... pinkston lawn mower wadesboro ad
CYCN Cyclerion Therapeutics Inc. Company Profile & Executives …
WebMar 24, 2024 · Ms. Lovell is currently on the board of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ), and she serves on the boards of several non-profit organizations. She holds a bachelor's degree from... WebApr 26, 2024 · CAMBRIDGE, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a … WebAug 9, 2024 · Appointed Steven E. Hyman, M.D. to its Board of Directors CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: … steffany frizzell gretzinger with husband